Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Financial Officer

President and CEO

Chief Scientific Officer

COO & CBO

Chief Legal Officer

Chief Commercial Officer

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's product portfolio includes ORMD-0801 Type 2, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes; ORMD-0801, Phase 2 oral insulin capsule for non-alcoholic steatohepatitis, a progressive liver diseases; and ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-17	Premium	acquired	Premium	Premium	Premium	-
2024-01-30	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-01-04	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-01-04	Premium	acquired	Premium	Premium	Premium	COO & CBO
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2024-01-04	Premium	acquired	Premium	Premium	Premium	-
2023-05-26	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-05-26	Premium	acquired	Premium	Premium	Premium	COO & CBO
2023-05-26	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-05-26	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-05-26	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-05-01	Premium	acquired	Premium	Premium	Premium	-
2023-04-17	Premium	acquired	Premium	Premium	Premium	-
2023-04-17	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-04-17	Premium	acquired	Premium	Premium	Premium	-
2023-04-17	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-04-17	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2023-04-17	Premium	acquired	Premium	Premium	Premium	-
2023-04-17	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-04-17	Premium	acquired	Premium	Premium	Premium	COO & CBO

ORMP - Oramed Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ORMP